Cellromax Science Co., Ltd.

471820· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩3,985-0.25%

2026-11-02

Financials

Valuation Metrics

Cellromax Science Co., Ltd.'s Market Cap is ₩450B. At end of 2025 it was ₩735B. Ranked #1783 of 2,405 in KR market (top 74%), #1091 of 1,627 on KOSDAQ (top 67%), #191 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 83%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	45.04B KRW	KR#1,783/2,405 Sec#191/231
Revenue	19.60B KRW	KR#2,133/2,405 Sec#157/231
Net Income	2.97B KRW	KR#1,348/2,405 Sec#94/231
Total Assets	50.54B KRW	KR#2,194/2,405 Sec#198/231
Net Assets	46.92B KRW	KR#1,943/2,405 Sec#163/231
Value
P/E	15.18x	KR#1,096/2,405 Sec#68/231
P/B	0.96x	KR#1,503/2,405 Sec#92/231
P/S	2.30x	KR#1,906/2,405 Sec#111/231
FCF Yield	3.79%	KR#956/2,405 Sec#59/231
Profitability
ROE	6.32%	KR#951/2,405 Sec#67/231
ROA	5.87%	KR#639/2,405 Sec#52/231
Op. Margin	10.98%	KR#473/2,405 Sec#42/231
Revenue Growth	2.56%	KR#1,339/2,405 Sec#134/231
Earnings Growth	-22.29%	KR#939/2,405 Sec#60/231
Financial Health
Debt Ratio	7.72%	KR#82/2,405 Sec#17/231
FCF	1.71B KRW	KR#1,102/2,405 Sec#80/231
Cash	3.35B KRW	KR#2,132/2,405 Sec#201/231
Current Ratio	5.98x	KR#215/2,405 Sec#44/231
Dividend
Div. Yield	4.63%	KR#352/2,405 Sec#12/231
Div. Growth	12.12%	KR#558/2,405 Sec#31/231
Performance
1Y Return	-20.78%	KR#1,146/2,405 Sec#80/231
1M Return	-3.28%	KR#561/2,405 Sec#53/231
From 52W High	-48.18%	KR#1,084/2,405 Sec#78/231
1Y MDD	-46.78%	KR#809/2,405 Sec#61/231
Trading
Volume	1,589 shares	KR#2,286/2,405 Sec#230/231
Trading Value	6.3M KRW	KR#2,294/2,405 Sec#229/231
Foreign Own.	0.67%	KR#2,141/2,405 Sec#209/231
Per Share
EPS	262 KRW	KR#1,206/2,405 Sec#83/231
BPS	4,151 KRW	KR#1,649/2,405 Sec#120/231